7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 
      
    		                            
      assets
    		                            
      current assets:
    		                            
      cash and cash equivalents
    		76,503,000 44,771,000 37,973,000 33,021,000 37,159,000 47,545,000 72,552,000 74,555,000 101,964,000 131,540,000 195,555,000 154,323,000 184,231,000 172,265,000 454,620,000 329,152,000 516,532,000 125,713,000 110,703,000 49,969,000 84,979,000 92,501,000 160,917,000 89,641,000 86,974,000 69,208,000 60,954,000 65,470,000 
      marketable securities
    		214,605,000 262,509,000 316,578,000 380,376,000 420,043,000 455,789,000 489,531,000 474,306,000 486,897,000 498,508,000 473,774,000 558,528,000 574,075,000 636,590,000 413,951,000 406,099,000 261,318,000 193,857,000 252,041,000 363,339,000 376,735,000 411,139,000 387,618,000 263,432,000 294,472,000 341,725,000 375,641,000 224,938,000 
      prepaid expenses and other current assets
    		9,277,000 11,898,000 12,099,000 11,420,000 12,162,000 16,367,000 19,307,000 16,946,000 13,821,000 10,119,000 11,974,000 10,997,000 10,166,000 9,350,000 9,536,000 7,071,000 8,585,000 9,760,000 11,993,000 8,203,000 8,298,000 6,448,000 7,669,000 4,364,000 4,037,000 3,664,000 5,519,000 2,768,000 
      total current assets
    		300,385,000 319,178,000 366,650,000 424,817,000 469,364,000 519,701,000 581,390,000 565,807,000 613,147,000 647,992,000 686,002,000 726,435,000 774,963,000 827,021,000 890,926,000 749,713,000 788,019,000 329,330,000 374,737,000 421,511,000 470,012,000 510,088,000 556,204,000 357,437,000 385,483,000 414,597,000 442,114,000 293,176,000 
      property and equipment
    		12,714,000 13,914,000 16,207,000 17,145,000 18,216,000 19,950,000 20,835,000 21,861,000 23,115,000 24,289,000 24,998,000 25,521,000 26,289,000 26,034,000 26,228,000 27,330,000 27,898,000 28,701,000 29,469,000 30,181,000 30,583,000 31,516,000 32,670,000 33,852,000 33,861,000 32,014,000 21,733,000 10,937,000 
      operating lease right-of-use assets
    		15,869,000 16,990,000 19,082,000 19,951,000 20,809,000 23,417,000 24,321,000 25,195,000 26,039,000 26,302,000 27,066,000 27,811,000 28,530,000 29,226,000 29,899,000 30,569,000 31,121,000 31,617,000 32,094,000 32,470,000 27,304,000 27,868,000 28,179,000 28,476,000 28,765,000 29,058,000 30,665,000  
      restricted cash
    		1,846,000 1,846,000 1,846,000 1,846,000 1,546,000 1,546,000 1,546,000 1,546,000 1,546,000 1,549,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 1,472,000 
      other assets
    		4,471,000 4,494,000 4,518,000 4,544,000 6,088,000 6,115,000 7,402,000 7,418,000 8,548,000 8,605,000 8,804,000 6,409,000 5,784,000 5,919,000 5,932,000 5,574,000 5,716,000 5,993,000 2,592,000 2,617,000 2,217,000 1,086,000 403,000 676,000 149,000 110,000 60,000 2,774,000 
      total assets
    		335,285,000 356,422,000 408,303,000 468,303,000 516,023,000 570,729,000 635,494,000 621,827,000 672,395,000 708,737,000 748,342,000 787,648,000 837,038,000 889,672,000 954,457,000 814,658,000 854,226,000 397,113,000 440,364,000 488,251,000 531,588,000 572,030,000 618,928,000 421,913,000 449,730,000 477,251,000 496,044,000 308,359,000 
      liabilities and stockholders’ equity
    		                            
      current liabilities:
    		                            
      accounts payable
    		4,757,000 2,217,000 2,326,000 2,215,000 5,017,000 4,375,000 4,586,000 3,775,000 4,679,000 4,667,000 3,126,000 4,189,000 4,546,000 4,646,000 6,752,000 4,749,000 2,341,000 11,942,000 5,310,000 3,004,000 1,370,000 4,760,000 4,039,000 278,000 258,000 540,000 1,200,000 126,000 
      accrued clinical supply costs
    		3,547,000 5,150,000 5,831,000 6,989,000 3,379,000 2,738,000 5,870,000 5,215,000 7,430,000 6,536,000 7,691,000 5,559,000 5,444,000 6,142,000 12,618,000 8,748,000 7,418,000 7,174,000 9,384,000 11,148,000 9,320,000 6,102,000 12,315,000 6,706,000 6,412,000 5,981,000 3,723,000 4,463,000 
      accrued liabilities
    		18,332,000 14,215,000 17,320,000 28,890,000 25,696,000 23,081,000 19,385,000 30,378,000 30,423,000 22,918,000 18,580,000 27,771,000 23,225,000 23,705,000 20,042,000 27,460,000 20,586,000 22,100,000 18,970,000 22,538,000 27,065,000 15,576,000 16,709,000 18,256,000 16,546,000 14,577,000 8,000,000 8,439,000 
      deferred revenue, current portion
    		11,743,000 13,402,000 21,850,000 23,663,000 55,427,000 63,961,000 73,352,000 82,975,000 80,561,000 68,550,000 61,773,000 48,231,000 119,684,000 106,994,000 95,611,000 90,803,000 94,683,000 25,417,000 22,700,000 23,886,000 26,596,000 32,739,000 32,089,000 30,165,000 29,527,000 40,871,000 38,526,000 34,905,000 
      payable to collaboration partner
    		10,788,000 6,607,000 9,045,000 5,914,000 6,772,000 5,813,000 15,632,000 7,703,000                     
      refund liability to collaboration partner, current portion
    		21,818,000 33,859,000 44,571,000 48,634,000 37,554,000 39,107,000 37,557,000 39,440,000 23,919,000 21,400,000                   
      operating lease liabilities, current portion
    		8,979,000 8,904,000 8,830,000 8,754,000 8,680,000 8,607,000 8,535,000 8,462,000 8,390,000 8,199,000 8,130,000 8,059,000 7,990,000 7,922,000 7,855,000 7,795,000 7,787,000 7,760,000 7,698,000 7,512,000 6,736,000 6,679,000 6,623,000 6,565,000 5,975,000 5,133,000 4,385,000  
      total current liabilities
    		79,964,000 84,354,000 109,773,000 125,059,000 142,525,000 147,682,000 164,917,000 177,948,000 155,402,000 132,270,000 99,300,000 93,809,000 160,889,000 149,409,000 142,878,000 139,555,000 132,815,000 74,393,000 64,062,000 68,088,000 71,087,000 65,856,000 71,775,000 61,970,000 58,718,000 67,102,000 55,834,000 47,948,000 
      deferred revenue, long-term portion
    		167,269,000 168,870,000 170,308,000 172,169,000 192,775,000 199,583,000 204,575,000 210,845,000 229,848,000 245,343,000 431,079,000 443,370,000 386,357,000 413,899,000 505,133,000 334,415,000 344,529,000 96,208,000 105,493,000 108,417,000 110,560,000 110,321,000 114,141,000 123,236,000 129,875,000 121,227,000 130,489,000 139,715,000 
      long-term debt
    		9,611,000 9,536,000 9,464,000 9,389,000                         
      refund liability to collaboration partner, long-term portion
    		   9,276,000 34,597,000 44,157,000 56,700,000 67,047,000 91,849,000 101,175,000                   
      operating lease liabilities, long-term portion
    		19,285,000 21,043,000 22,754,000 24,376,000 25,959,000 27,506,000 29,022,000 30,456,000 31,843,000 32,745,000 34,050,000 35,268,000 36,455,000 37,615,000 38,751,000 39,806,000 40,834,000 41,839,000 42,822,000 43,744,000 39,257,000 40,029,000 40,785,000 41,471,000 42,141,000 42,797,000 43,439,000  
      other long-term liabilities
    		1,444,000 1,444,000 1,394,000 1,234,000 1,234,000 1,234,000 1,373,000 1,373,000 898,000 898,000 898,000 759,000 233,000 233,000 158,000 158,000 158,000 158,000 158,000 472,000 493,000 493,000 493,000 493,000 409,000 409,000 96,000 96,000 
      total liabilities
    		277,573,000 285,247,000 313,693,000 341,503,000 397,090,000 420,162,000 456,587,000 487,669,000 509,840,000 512,431,000 565,327,000 573,206,000 583,934,000 601,156,000 686,920,000 513,934,000 518,336,000 212,598,000 212,535,000 220,721,000 221,397,000 216,699,000 227,194,000 227,170,000 231,143,000 231,535,000 229,858,000 195,237,000 
      commitments and contingencies
    		                            
      stockholders’ equity:
    		                            
      common stock
    		10,000 9,000 9,000 9,000 9,000 9,000 9,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 8,000 7,000 7,000 7,000 7,000 1,000 
      additional paid-in capital
    		992,294,000 971,192,000 964,008,000 955,657,000 945,046,000 936,011,000 925,458,000 844,044,000 831,912,000 821,853,000 810,750,000 798,696,000 787,097,000 775,843,000 762,458,000 748,036,000 726,692,000 701,670,000 689,630,000 676,956,000 666,958,000 658,642,000 648,783,000 414,414,000 407,647,000 402,823,000 399,066,000 17,078,000 
      accumulated other comprehensive income
    		197,000 96,000 191,000 261,000 931,000 -620,000 -403,000 184,000        -943,000 -41,000 203,000 410,000 614,000 1,094,000 1,846,000 2,782,000 142,000 226,000 441,000 108,000  
      accumulated deficit
    		-934,789,000 -900,122,000 -869,598,000 -829,127,000 -827,053,000 -784,833,000 -746,157,000 -710,078,000 -668,644,000 -624,169,000 -625,544,000 -579,687,000 -527,259,000 -481,111,000 -490,994,000 -446,377,000 -390,769,000 -517,366,000 -462,219,000 -410,048,000 -357,869,000 -305,165,000 -259,839,000 -219,820,000 -189,293,000 -157,555,000 -132,995,000 -114,435,000 
      total stockholders’ equity
    		57,712,000 71,175,000 94,610,000 126,800,000 118,933,000 150,567,000 178,907,000 134,158,000                 218,587,000 245,716,000 266,186,000  
      total liabilities and stockholders’ equity
    		335,285,000 356,422,000 408,303,000 468,303,000 516,023,000 570,729,000 635,494,000 621,827,000         854,226,000 397,113,000 440,364,000  531,588,000 572,030,000 618,928,000      
      receivable from collaboration partner
    		        10,465,000 7,825,000 4,699,000 2,587,000 6,491,000 8,816,000 12,819,000 7,391,000 1,584,000            
      liabilities and stockholders' equity
    		                            
      stockholders' equity:
    		                            
      accumulated other comprehensive loss
    		        -721,000 -1,386,000 -2,199,000 -4,575,000 -6,742,000 -6,224,000 -3,935,000             -42,000 
      total stockholders' equity
    		        162,555,000 196,306,000 183,015,000 214,442,000 253,104,000 288,516,000 267,537,000 300,724,000 335,890,000 184,515,000 227,829,000 267,530,000 310,191,000 355,331,000 391,734,000 194,743,000     
      total liabilities and stockholders' equity
    		        672,395,000 708,737,000 748,342,000 787,648,000 837,038,000 889,672,000 954,457,000 814,658,000    488,251,000         
      liabilities, convertible preferred stock, and stockholders' equity
    		                            
      deferred rent, current portion
    		                           15,000 
      deferred rent, long-term portion
    		                           7,478,000 
      convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of december 31, 2019 and 2018, respectively; zero and 45,374,836 shares issued and outstanding as of december 31, 2019 and 2018, respectively
    		                            
      stockholders' equity
    		                            
      total liabilities, convertible preferred stock, and stockholders' equity
    		                       421,913,000     
      liabilities, convertible preferred stock, and stockholders’ equity
    		                            
      convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of september 30, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of september 30, 2019 and december 31, 2018, respectively
    		                            
      stockholders’ equity
    		                            
      total liabilities, convertible preferred stock, and stockholders’ equity
    		                        449,730,000 477,251,000 496,044,000  
      convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of june 30, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of june 30, 2019 and december 31, 2018, respectively
    		                            
      convertible preferred stock; 0.0001 par value; zero and 45,849,677 shares authorized as of march 31, 2019 and december 31, 2018, respectively; zero and 45,374,836 shares issued and outstanding as of march 31, 2019 and december 31, 2018, respectively
    		                            
      accounts receivable
    		                            
      liabilities, convertible preferred stock, and stockholders’ deficit
    		                            
      convertible preferred stock; 0.0001 par value; 45,849,677 and 36,001,203 shares authorized as of december 31, 2018 and 2017, respectively; 45,374,836 and 36,001,203 shares issued and outstanding as of december 31, 2018 and 2017, respectively; liquidation preference of 211,054 as of december 31, 2018
    		                           210,520,000 
      stockholders’ deficit:
    		                            
      total stockholders’ deficit
    		                           -97,398,000 
      total liabilities, convertible preferred stock, and stockholders’ deficit
    		                           308,359,000 
      revenue:
    		                            
      collaboration revenue
    		                           27,508,000 
      grant revenue
    		                           169,000 
      total revenue
    		                           27,677,000 
      operating expenses:
    		                            
      research and development
    		                           73,031,000 
      general and administrative
    		                           11,934,000 
      total operating expenses
    		                           84,965,000 
      income from operations
    		                           -57,288,000 
      other income
    		                           5,040,000 
      net income
    		                           -52,248,000 
      unrealized loss on marketable securities
    		                           -42,000 
      comprehensive loss
    		                           -52,290,000 
      net income per share
    		                           -4,620 
      shares used in computing net income per share, basic and diluted
    		                           11,302,788,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.